Hisamitsu Sales Down 3.4% on Price Cuts, Generic Erosion

April 11, 2019
Patch drug powerhouse Hisamitsu Pharmaceutical saw its group sales shrivel 3.4% year on year to 143.4 billion yen in the year ended in February, with its operating profit plunging 17.3%, as it suffered last April’s price cuts in Japan and...read more